000 02115 a2200625 4500
005 20250516154541.0
264 0 _c20131125
008 201311s 0 0 eng d
022 _a1432-0584
024 7 _a10.1007/s00277-013-1807-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHuang, Yu-Chung
245 0 0 _aComparison of prognostic models for patients with diffuse large B-cell lymphoma in the rituximab era.
_h[electronic resource]
260 _bAnnals of hematology
_cNov 2013
300 _a1513-20 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
_xadministration & dosage
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aCohort Studies
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aLymphoma, Large B-Cell, Diffuse
_xdiagnosis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aModels, Biological
650 0 4 _aPrednisone
_xadministration & dosage
650 0 4 _aPrognosis
650 0 4 _aRituximab
650 0 4 _aSurvival Rate
_xtrends
650 0 4 _aVincristine
_xadministration & dosage
650 0 4 _aYoung Adult
700 1 _aLiu, Chun-Yu
700 1 _aLu, Hsueh-Ju
700 1 _aLiu, Han-Tsung
700 1 _aHung, Man-Hsin
700 1 _aHong, Ying-Chung
700 1 _aHsiao, Liang-Tsai
700 1 _aGau, Jyh-Pyng
700 1 _aLiu, Jin-Hwang
700 1 _aHsu, Hui-Chi
700 1 _aChiou, Tzeon-Jye
700 1 _aChen, Po-Min
700 1 _aTzeng, Cheng-Hwai
700 1 _aYu, Yuan-Bin
773 0 _tAnnals of hematology
_gvol. 92
_gno. 11
_gp. 1513-20
856 4 0 _uhttps://doi.org/10.1007/s00277-013-1807-0
_zAvailable from publisher's website
999 _c22844549
_d22844549